Armata Pharmaceuticals, Inc. — Director's Dealing 2006

Sep 5, 2006

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2006-09-05

Reporting Person: PARKER H STEWART (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2006-09-05	Common Stock	P	60	$1.91	Acquired	21235	Direct
2006-09-05	Common Stock	P	1300	$1.95	Acquired	22535	Direct
2006-09-05	Common Stock	P	200	$1.99	Acquired	22735	Direct
2006-09-05	Common Stock	P	8440	$2.00	Acquired	31175	Direct

Footnotes

F1: Such amount reflects a 10-for-1 reverse stock split effected May 10, 2006.